There are no products listed under this category.
PNPLA8
PNPLA8 (patatin like domain 8, phospholipase A2), also known as iPLA2gamma, IPLA2-2 or IPLA2G, is a calcium-independent, membrane-bound phospholipase. It releases fatty acids from glycerophospholipids and helps maintain mitochondrial membrane lipid composition. Browse Assay Genie's current range of PNPLA8 research reagents below, or read on for the biology behind the target.
PNPLA8 is a calcium-independent, membrane-bound phospholipase that catalyses the esterolytic cleavage of fatty acids from glycerophospholipids, yielding free fatty acids and lysophospholipids. In doing so it regulates membrane physical properties and the release of lipid second messengers and growth factors. It hydrolyses phosphatidylethanolamine, phosphatidylcholine and probably phosphatidylinositol, with a possible preference for phosphatidylethanolamine, and it can also hydrolyse lysophosphatidylcholine.
The enzyme has broad fatty acid specificity. It removes saturated and mono-unsaturated fatty acids at nearly equal rates from either the sn-1 or sn-2 position of diacyl phosphatidylcholine, but shows weak activity toward polyunsaturated fatty acids at sn-2. This favours production of 2-arachidonoyl lysophosphatidylcholine, a key branch point metabolite in eicosanoid signalling. PNPLA8 can also release arachidonic acid from the sn-1 position of diacyl phospholipids and from the sn-2 position of arachidonate-containing plasmalogens, so it contributes to arachidonic acid mobilisation in response to cellular stimuli. In mitochondria it hydrolyses and releases oxidised aliphatic chains from cardiolipin, linking bioenergetics with signalling, and it is essential for efficient mitochondrial function through tailoring of membrane lipid metabolism and composition. The protein is found at endoplasmic reticulum, mitochondrial and peroxisomal membranes.
The PNPLA8 gene encodes a member of the patatin-like phospholipase domain containing family, whose members cleave fatty acids from membrane phospholipids. Mutations in the gene have been associated with mitochondrial myopathy with lactic acidosis, and multiple transcript variants encoding different isoforms have been reported. Earlier HGNC names include patatin-like phospholipase domain containing 8, and the enzyme is also called calcium-independent phospholipase A2-gamma.
PNPLA8 generates lysophospholipids and free fatty acids that act as lipid second messengers and growth factors.
Its handling of arachidonate-containing substrates makes it relevant to arachidonic acid mobilisation and the 2-arachidonoyl lysophosphatidylcholine branch point in eicosanoid signalling.
PNPLA8 hydrolyses oxidised chains from cardiolipin and is essential for efficient mitochondrial function and membrane lipid composition.
Mutations in the PNPLA8 gene are associated with mitochondrial myopathy with lactic acidosis.
PNPLA8 is a calcium-independent phospholipase that cleaves fatty acids from glycerophospholipids, producing free fatty acids and lysophospholipids. It mobilises arachidonic acid, generates lipid second messengers, and in mitochondria removes oxidised chains from cardiolipin to support bioenergetic function.
PNPLA8 is also called iPLA2gamma, IPLA2-2 and IPLA2G, and its protein name is calcium-independent phospholipase A2-gamma. Earlier HGNC names were patatin-like phospholipase domain containing 8. Multiple transcript variants encoding different isoforms have been described for the gene.
Mutations in the PNPLA8 gene have been associated with mitochondrial myopathy with lactic acidosis. Orthologues exist in mouse and rat, both named Pnpla8; check the datasheet of any product for its validated reactivity.
Other patatin-like phospholipase domain containing proteins and lipid-metabolism enzymes with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q9NP80; product specifications from Assay Genie datasheets.
There are no products listed under this category.